Metabolic reprogramming and redox adaptation in sorafenib-resistant leukemia cells: detected by untargeted metabolomics and stable isotope tracing analysis

BACKGROUND: Internal tandem duplications (ITD) within the juxtamembrane domain of FMS-like tyrosine kinase 3 (FLT3) represent a poor prognostic indicator in acute myeloid leukemia (AML). Therapeutic benefits of tyrosine kinase inhibitors, such as sorafenib, are limited due to the emergence of drug r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Commun (Lond)
Autors principals: You, Xin, Jiang, Weiye, Lu, Wenhua, Zhang, Hui, Yu, Tiantian, Tian, Jingyu, Wen, Shijun, Garcia-Manero, Guillermo, Huang, Peng, Hu, Yumin
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6449955/
https://ncbi.nlm.nih.gov/pubmed/30947742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-019-0362-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars